Literature DB >> 30415588

Cost-effectiveness analysis and safety of erythromycin 4% gel and 4% chlorhexidine scrub for pitted keratolysis treatment.

Charussri Leeyaphan1, Sumanas Bunyaratavej1, Suthira Taychakhoonavudh2, Nattanichcha Kulthanachairojana2,3, Penvadee Pattanaprichakul1, Pattriya Chanyachailert1, Punyawee Ongsri1, Sittiroj Arunkajohnsak1, Pichaya Limphoka1, Kanokvalai Kulthanan1.   

Abstract

Background: Studies of Pitted keratolysis (PK) treatment are limited.
Objectives: To study cost-effectiveness and to compare the safety of 4% chlorhexidine scrub with 4% erythromycin gel, for PK infections. Materials and methods: This cohort study was conducted on naval rating cadets with a clinical diagnosis of PK at Chumpol Naval Rating School, Thailand in 2016. Participants were randomly treated with either 4% erythromycin gel or 4% chlorhexidine scrub for 4 weeks. The clinical examinations were evaluated at the baseline and at 1 and 2 months after treatment. A decision-tree model was used to evaluate the costs, resource utilization and outcomes as quality-adjusted life-years (QALYs).
Results: Of 344 naval rating cadets, 125 (36.3%) were diagnosed with PK. Sixty-four were treated with erythromycin. Approximately 80% of participants had complete resolution Foot odor were significantly improved at 2 months (p < .001) for both groups. No adverse effects were reported. Total cost for 4 weeks' treatment with the erythromycin gel and chlorhexidine scrub was US$77.34, US$51.9, respectively. Chlorhexidine treatment and erythromycin gel had 0.1526 and 0.1425 QALYs, respectively. Conclusions: treatment of PK with either 4% chlorhexidine scrub or 4% erythromycin gel had similar outcomes. However, using chlorhexidine scrub was more cost-effective.

Entities:  

Keywords:  Pitted keratolysis; chlorhexidine scrub; cost-effectiveness analysis; erythromycin gel; safety; treatment

Mesh:

Substances:

Year:  2018        PMID: 30415588     DOI: 10.1080/09546634.2018.1543846

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  1 in total

1.  The Correlations between Clinical Features, Dermoscopic and Histopathological Findings, and Treatment Outcomes of Patients with Pitted Keratolysis.

Authors:  Penvadee Pattanaprichakul; Kanokvalai Kulthanan; Sumanas Bunyaratavej; Sasima Eimpunth; Thanaporn Rungruang; Pattriya Chanyachailert; Punyawee Ongsri; Poramin Patthamalai; Kanyalak Munprom; Charussri Leeyaphan
Journal:  Biomed Res Int       Date:  2021-10-25       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.